Kemin Highlights Sustained UK Immune Supplement Growth Beyond Seasonal Focus

London, United Kingdom — 15 May 2024

Global ingredient supplier Kemin identifies a fundamental shift in UK consumer behaviour towards immune health supplements. Previously driven by seasonal concerns, demand now reflects an everyday wellness approach, a trend accelerated but not created by the COVID-19 pandemic. This sustained interest presents both opportunities and challenges for supplement manufacturers and brand owners operating in the British market.

The market is no longer solely focused on reactive immune support during peak cold and flu seasons. Consumers are integrating immune health into their daily routines, viewing it as foundational to overall well-being. This requires brands to move beyond traditional 'winter wellness' messaging and articulate year-round benefits, potentially leveraging ingredients with broader adaptogenic or long-term health properties. The shift also implies a higher frequency of purchase and a broader demographic appeal, extending beyond vulnerable populations to general health-conscious consumers.

Brand owners must refine their product development strategies, ensuring formulations cater to this continuous daily use. This includes considering palatability, dosage convenience, and synergistic ingredient combinations that support holistic health outcomes beyond immune function. For instance, combining immune support with gut health or stress management could resonate strongly with the 'everyday wellness' consumer. Ingredient suppliers like Kemin are positioned to benefit from this, but also face pressure to ensure consistent supply and competitive pricing for in-demand components.

Marketing and communication strategies must reflect this pivot. Generic claims of 'boosting immunity' are less effective than specific, evidence-backed benefits related to sustained cellular health, resilience, and general vitality. Regulatory compliance remains paramount; all claims must adhere strictly to UK Advertising Standards Authority (ASA) and Food Standards Agency (FSA) guidelines, particularly concerning health claims related to daily supplementation.

What this means for United Kingdom

UK manufacturers must reassess existing product portfolios, identifying gaps for daily-use immune formulations. This could lead to 10-15% reformulation costs over the next 18 months to align with 'everyday wellness' positioning. Brand owners should anticipate a greater emphasis on sustained, rather than acute, efficacy data in marketing materials to comply with FSA guidance. Procurement leads face intensified competition for core immune ingredients (e.g., Vitamin D, Zinc, Elderberry), potentially driving a 5-8% increase in raw material costs by Q4 2024. Establishing long-term supplier contracts and diversifying sourcing will be critical to maintaining margins and supply continuity.

The market is ripe for innovation in delivery formats and multi-benefit products that integrate immune support with other wellness categories.

Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.